This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
4. In Part 2 (which specifies the drugs which are subject to control under that Act as Class B drugs)—
(a)in paragraph 1(a)—
(i)after “Glutethimide”, insert—
“Ketamine.”;
(ii)after “Lefetamine”, insert—
“Lisdexamphetamine.”;
(b)after paragraph 1(d), insert—
“(e)Any compound (not being a compound for the time being specified in paragraph 1(ba) of Part 1 of this Schedule) structurally derived from 1-benzofuran, 2,3-dihydro-1-benzofuran, 1H-indole, indoline, 1H-indene, or indane by substitution in the 6-membered ring with a 2-ethylamino substituent whether or not further substituted in the ring system to any extent with alkyl, alkoxy, halide or haloalkyl substituents and whether or not substituted in the ethylamino side-chain with one or more alkyl substituents.”.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
